Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema
Hemal Mehta, Samantha Fraser-Bell, Nguyen Vuong, Lyndell L Lim, Mark C Gillies
British Journal of Ophthalmology | BMJ PUBLISHING GROUP | Published : 2018
This study was funded by a project grant from the National Health and Medical Research Council (NHMRC) Australia, which was supplemented by unrestricted educational grants from Allergan Pharmaceuticals and Alimera Sciences. MCG is a Sydney Medical School Foundation Fellow and is supported by an NHMRC Clinical Practitioner Fellowship. The funding bodies had no influence on the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript; and decision to submit for publication.